MRD Detection in Acute Lymphoblastic Leukemia Patients Using Ig/TCR Gene Rearrangements as Targets for Real-Time Quantitative PC
Minimal residual disease (MRD) diagnostics has proven to be clinically relevant for evaluation of treatment effectiveness in patients with acute lymphoblastic leukemia (ALL). In most ALL treatment protocols, MRD diagnostics is performed by real-time quantitative PCR (RQ-PCR) analysis of the junctional regions of rearranged immunoglobulin (Ig) and T-cell receptor (TCR) genes. MRD diagnostics via Ig/TCR genes is broadly applicable (>95% of ALL patients) and can reach a good sensitivity (≤10 −4 ). However, the technique is complex and requires extensive knowledge and experience, because the junctional regions of each leukemia have to be identified before the patient-specific RQ-PCR assays can be designed for MRD monitoring. This chapter provides all relevant background information and technical aspects for the complete laboratory process from detection of the clonal Ig/TCR gene rearrangements in ALL cells at diagnosis to the actual MRD measurements in clinical follow-up samples. This information aims at facilitating the PCR-based MRD diagnostics in ALL patients. However, it should be noted that MRD diagnostics for clinical treatment protocols has to be accompanied by regular international quality control rounds to ensure the reproducibility and reliability of the MRD results.
- Detection of Cancer-Related Proteins in Fresh-Frozen Ovarian Cancer Samples Using Laser Capture Microdissection
- Screening for EpsteinBarr Virus in Hodgkin's Lymphoma
- Isolation and Culture of Leukemia Cell Lines
- Manipulating Genes and Gene Copy Number by Bacterial Artificial Chromosome Transfection
- Elucidation of Signal Transduction Pathways by Retroviral Infection of Cells with Modified Oncogenes
- Immortalization of Human Prostate Cells With the Human Papillomavirus Type 16 E6 Gene
- Myeloperoxidase Promoter Region Polymorphism and Lung Cancer Risk
- Angiogenesis, Metastasis, and Lung Cancer: An Overview
- 萤光素酶载体PGL3转染细胞要不要加G418
- p53-Induced Gene Expression Analysis